Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Nu-Med Plus Inc. (OTC: NUMD).

Full DD Report for NUMD

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A0.85N/AN/A0
2018-12-13N/A0.85N/AN/A0
2018-12-12N/A0.85N/AN/A0
2018-12-11N/A0.85N/AN/A0
2018-12-10N/A0.85N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-261,0002,00050.0000Short
2018-10-261,00013,3707.4794Cover
2018-10-12415415100.0000Short
2018-10-101,5141,514100.0000Short
2018-10-092,6843,84869.7505Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NUMD.


About Nu-Med Plus Inc. (OTC: NUMD)

Logo for Nu-Med Plus Inc. (OTC: NUMD)

The mission of NU MED is to design, develop, and market technologies in the medical device field. Our technologies will focus on market niches in high growth trend areas. We hope each developed technology will fill a current need in medical procedures by improving upon an existing technology or device, or by designing a device to serve a need that is clearly defined and acknowledged by medical professionals.

 

Contact Information

 

 

Current Management

  • Jeffrey Lynn Robins / CEO, President
    • Mr. Robins has years of senior management experience in high technology companies coupled with years of engineering leadership experience. For the past five years, Mr. Robins has been a management consultant for his private consulting company Robins Resource Associates and worked as CEO of NUMED PLUS,Inc. Mr. Robins served as VP of Operations at TSCO CO., Inc. until where he was a member of the Executive Staff with responsibilities for accelerated new product development and operations management. Mr. Robins has extensive global experience including Operations Senior Director at Fujitsu Microelectronics, where he was responsible for foundry services, product development and two wafer fabrication plants from start up to full production and ultimately having P amp L responsibility for a million operation. He was Fabrication Director of Operations at International Rectifier and has held various positions at Intel and AMD. He is a past president of the Oregon Semiconductor Association. Mr. Robins holds a B.S. in Pharmacy from Idaho State University, a B.S. in Political Science from Weber State University and an Engineering Management Certificate from Idaho State University.
  • Dr. Brett Joesph Earl / SVP, Mkt. amp Comm.
    • Dr. Earl is a Board Certified Emergency Physician with over years experience in his field,not only as an Emergency Physician but he has also served as a Life Flight Helicopter Physician and a Tactical Physician for the city of Toledo, Ohio SWAT team. Dr. Earl received his Medical Degree from the University of Nevada, Reno. He has has been published a number of times and serves on various Medical Boards in Utah and his clinical interests include Trauma, I.V. Nutrition and Injections. After practicing Emergency Medicine for years, and noting the benefits and limitations of traditional western medicine, he opted to study and practice Functional Medicine, and focus on restoring health, preventing illness, and avoiding prescriptions and surgeries wherever possible. Dr. Earl currently practices Functional Medicine in Bountiful, Utah.
  • Thomas Alan Tait / SVP, Product Dev.
    • Mr. Tait s background spans years in the chemical industry. Mr. Tait holds an MBA in Technology Management and a BS in Chemistry from Clarkson University. , Mr. Tait was the General Manager HyperQuan, Inc., in Colorado Springs, Colorado. HyperQuan is a technology startup focused on analytical instrumentation. Prior assignments have included Product Manager J amp W Scientific and Project Manager Varian Inc. He also cofounded ChiraTech Inc, a high technology Company that was sold to Thermo Electron Corporation. He also holds patents in Optics and MEMS technologies along with multiple publications and citations in the chemical literature. Mr. Tait has been involved in several successful endeavors that have resulted in improved products or new product categories. Some highlights include a new synthetic pathway to Naprosyn Aleve in collaboration with Syntex Chemical, product development with M creating a new class of chemical sorbents Empore and development of novel support media for high temperature adsorption media.
  • William Grant Moon / SVP, Product Dev.
    • Mr. Moons background includes positions of Principle Engineer and VP of Engineering at Quantum Corporation, the world s largest disk drive company, where he was instrumental in growing the company to over , employees. He cofounded Plus Development, a wholly owned Quantum subsidiary and played a pivotal role in the invention of the Hardcard, the very first plugin hard drive card. Mr. Moon also helped craft a partnership with Panasonic for the worlds first totally automated disk drive assembly plant in Japan. Mr. Moon has served on the board of directors of several technical ventures and as an angel investor. He holds patents and has several publications in computer trade magazines. Mr. Moon holds a Masters and Bachelors degree in Mechanical Engineering, has received the Honored Alumni award, and has served as an adjunct professor.
  • Dr. Craig Wilbur Morrison / SVP, Exploration
    • Dr. Morrison is a surgeon in the State of Utah. He has been an attending and consulting staff general surgeon since . Dr. Morrison received his Doctor of Medicine Degree from the University of Oregon Medical School in , followed by a pediatric internship and surgical residency at the University of Southern CaliforniaLos Angeles County Hospital and the Huntington Memorial Hospital. He has provided his medical expertise and is one of the pioneering shareholders in the finance and development of synthetic alternatives to blood for Sanguine Corporation. Dr. Morrison has served on the medical advisory board of Sanguine Corporation, Rubicon, Inc and Reflect Scientific Inc. Dr. Morrison has participated in various humanitarian efforts worldwide throughout his career.
  • Keith LaVon Merrell / CFO
    • Mr. Merrell has prior experience as a CFO with a public company and is a CPA. Mr. Merrell has more than thirty years of accounting experience managing both public and private enterprises. Prior to joining the Company, Mr. Merrell served as the CFO of GeNOsys, Inc. from to . Prior to joining GeNOsys, Mr. Merrell served as Chief Financial Officer of Specialized Health Products International, Inc., a company that specialized in the manufacture of safety medical devices from to . Mr. Merrell joined NuMed Plus, Inc. in and presently serves as there CFO. Mr. Merrell earned a Bachelor of Science in Accounting from Arizona State University.
  • Dr. Charles Ivester / Advisory Director
    • Dr. Ivester received his PhD. and M.D. from the Medical University of South Carolina and is a board certified in Pulmonary Disease, Internal, Critical Care, and Sleep Medicine while holding licensure as a physician and surgeon in the State of Utah. He has participated in countless research ventures, been published numerous times while presenting his findings at a variety of national and international venues along with serving as an educator/teacher at a number of conferences and medical related schools. Dr. Ivester presently practices as a pulmonary and critical care physician at Ogden Pulmonary Associates in Ogden Utah.
  • Jeffrey Lynn Robins / Chairman
    • Mr. Robins has years of senior management experience in high technology companies coupled with years of engineering leadership experience. For the past five years, Mr. Robins has been a management consultant for his private consulting company Robins Resource Associates and worked as CEO of NUMED PLUS,Inc. Mr. Robins served as VP of Operations at TSCO CO., Inc. until where he was a member of the Executive Staff with responsibilities for accelerated new product development and operations management. Mr. Robins has extensive global experience including Operations Senior Director at Fujitsu Microelectronics, where he was responsible for foundry services, product development and two wafer fabrication plants from start up to full production and ultimately having P amp L responsibility for a million operation. He was Fabrication Director of Operations at International Rectifier and has held various positions at Intel and AMD. He is a past president of the Oregon Semiconductor Association. Mr. Robins holds a B.S. in Pharmacy from Idaho State University, a B.S. in Political Science from Weber State University and an Engineering Management Certificate from Idaho State University.
  • Dr. Brett Joesph Earl / Director
    • Dr. Earl is a Board Certified Emergency Physician with over years experience in his field,not only as an Emergency Physician but he has also served as a Life Flight Helicopter Physician and a Tactical Physician for the city of Toledo, Ohio SWAT team. Dr. Earl received his Medical Degree from the University of Nevada, Reno. He has has been published a number of times and serves on various Medical Boards in Utah and his clinical interests include Trauma, I.V. Nutrition and Injections. After practicing Emergency Medicine for years, and noting the benefits and limitations of traditional western medicine, he opted to study and practice Functional Medicine, and focus on restoring health, preventing illness, and avoiding prescriptions and surgeries wherever possible. Dr. Earl currently practices Functional Medicine in Bountiful, Utah.
  • William Grant Moon / Director
    • Mr. Moons background includes positions of Principle Engineer and VP of Engineering at Quantum Corporation, the world s largest disk drive company, where he was instrumental in growing the company to over , employees. He cofounded Plus Development, a wholly owned Quantum subsidiary and played a pivotal role in the invention of the Hardcard, the very first plugin hard drive card. Mr. Moon also helped craft a partnership with Panasonic for the worlds first totally automated disk drive assembly plant in Japan. Mr. Moon has served on the board of directors of several technical ventures and as an angel investor. He holds patents and has several publications in computer trade magazines. Mr. Moon holds a Masters and Bachelors degree in Mechanical Engineering, has received the Honored Alumni award, and has served as an adjunct professor.
  • Dr. Craig Wilbur Morrison / Director
    • Dr. Morrison is a surgeon in the State of Utah. He has been an attending and consulting staff general surgeon since . Dr. Morrison received his Doctor of Medicine Degree from the University of Oregon Medical School in , followed by a pediatric internship and surgical residency at the University of Southern CaliforniaLos Angeles County Hospital and the Huntington Memorial Hospital. He has provided his medical expertise and is one of the pioneering shareholders in the finance and development of synthetic alternatives to blood for Sanguine Corporation. Dr. Morrison has served on the medical advisory board of Sanguine Corporation, Rubicon, Inc and Reflect Scientific Inc. Dr. Morrison has participated in various humanitarian efforts worldwide throughout his career.
  • Thomas Alan Tait / Director
    • Mr. Tait s background spans years in the chemical industry. Mr. Tait holds an MBA in Technology Management and a BS in Chemistry from Clarkson University. , Mr. Tait was the General Manager HyperQuan, Inc., in Colorado Springs, Colorado. HyperQuan is a technology startup focused on analytical instrumentation. Prior assignments have included Product Manager J amp W Scientific and Project Manager Varian Inc. He also cofounded ChiraTech Inc, a high technology Company that was sold to Thermo Electron Corporation. He also holds patents in Optics and MEMS technologies along with multiple publications and citations in the chemical literature. Mr. Tait has been involved in several successful endeavors that have resulted in improved products or new product categories. Some highlights include a new synthetic pathway to Naprosyn Aleve in collaboration with Syntex Chemical, product development with M creating a new class of chemical sorbents Empore and development of novel support media for high temperature adsorption media.

Current Share Structure

  • Market Cap: $15,224,908 - 03/16/2018
  • Authorized: 90,000,000 - 11/27/2017
  • Issue and Outstanding: 38,062,269 - 11/27/2017
  • Float: 7,285,367 - 11/27/2017

 


Recent Filings from (OTC: NUMD)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 03 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: April, 03 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 14 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: December, 14 2017
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: December, 04 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2017
Amendment to a previously filed Form D
Filing Type: D/AFiling Source: edgar
Filing Date: September, 20 2017

 

 


Daily Technical Chart for (OTC: NUMD)

Daily Technical Chart for (OTC: NUMD)


Stay tuned for daily updates and more on (OTC: NUMD)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: NUMD)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NUMD is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NUMD and does not buy, sell, or trade any shares of NUMD. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/